Literature DB >> 16729969

Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension.

Lunyin Yu1, Deborah A Quinn, Hari G Garg, Charles A Hales.   

Abstract

The balance between cell proliferation and cell quiescence is regulated delicately by a variety of mediators, in which cyclin-dependent kinases (CDK) and CDK inhibitors (CDKI) play a very important role. Heparin which inhibits pulmonary artery smooth muscle cell (PASMC) proliferation increases the levels of two CDKIs, p21 and p27, although only p27 is important in inhibition of PASMC growth in vitro and in vivo. In the present study we investigated the expression profile of all the cell cycle regulating genes, including all seven CDKIs (p21, p27, p57, p15, p16, p18, and p19), in the lungs of mice with hypoxia-induced pulmonary hypertension. A cell cycle pathway specific gene microarray was used to profile the 96 genes involved in cell cycle regulation. We also observed the effect of heparin on gene expression. We found that (a) hypoxic exposure for two weeks significantly inhibited p27 expression and stimulated p18 activity, showing a 98% decrease in p27 and 81% increase in p18; (b) other CDKIs, p21, p57, p15, p16, and p19 were not affected significantly in response to hypoxia; (c) heparin treatment restored p27 expression, but did not influence p18; (d) ERK1/2 and p38 were mediators in heparin upregulation of p27. This study provides an expression profile of cell cycle regulating genes under hypoxia in mice with hypoxia-induced pulmonary hypertension and strengthens the previous finding that p27 is the only CDKI involved in heparin regulation of PASMC proliferation and hypoxia-induced pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729969     DOI: 10.1016/j.bbrc.2006.05.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.

Authors:  Soni Savai Pullamsetti; Rajkumar Savai; Werner Seeger; Elena A Goncharova
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

2.  Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1.

Authors:  Lunyin Yu; Charles A Hales
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-31       Impact factor: 6.914

3.  Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension.

Authors:  I Morecroft; B Doyle; M Nilsen; W Kolch; K Mair; M R Maclean
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nucleotide exchange factor-H1/RhoA/Rho kinase/p27.

Authors:  Lunyin Yu; Deborah A Quinn; Hari G Garg; Charles A Hales
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-17       Impact factor: 6.914

5.  Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways.

Authors:  Shiro Mizuno; Herman J Bogaard; Norbert F Voelkel; Yukihiro Umeda; Maiko Kadowaki; Shingo Ameshima; Isamu Miyamori; Takeshi Ishizaki
Journal:  Respir Res       Date:  2009-03-06

6.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

7.  Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.

Authors:  Hicham Mrabat; Hari G Garg; Charles A Hales
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

8.  Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling.

Authors:  Lunyin Yu; Deborah A Quinn; Hari G Garg; Charles A Hales
Journal:  Am J Respir Crit Care Med       Date:  2008-02-28       Impact factor: 21.405

9.  Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.

Authors:  YanBiao Chu; XiaoYing XiangLi; Hu Niu; HongChao Wang; PingDong Jia; WenBin Gong; DaWei Wu; WeiDong Qin; ChunYan Xing
Journal:  Mol Cell Biochem       Date:  2015-11-25       Impact factor: 3.396

10.  Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.

Authors:  Ying Luo; Dun-Quan Xu; Hai-Ying Dong; Bo Zhang; Yi Liu; Wen Niu; Ming-Qing Dong; Zhi-Chao Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.